Market Research Report
Asia Pacific Balloon Catheters Market Forecast 2019-2027
|Published by||Inkwood Research||Product code||798105|
|Published||Content info||92 Pages
Delivery time: 2-3 business days
|Asia Pacific Balloon Catheters Market Forecast 2019-2027|
|Published: March 4, 2019||Content info: 92 Pages||
The APAC market for PTCA balloon catheters is expected to progress at a CAGR of 5.27% from 2019 to 2027. The increasing disposable incomes and the subsequent growth prospects in the emerging economies are primarily driving the market growth in the Asia Pacific.
China, Japan, India, Australia, South Korea, and other regions of Asia-Pacific called Rest of APAC are considered for the market analysis. The Asia Pacific PTCA balloon catheters market has the fastest growth in the global scenario during the forecast period. The rapid rise in geriatric population, improving healthcare infrastructure, increasing awareness, and affordability for the use of PTCA balloon catheters are majorly responsible for the market growth. The high incidences of stroke and other CHD led to increased use of PTCA balloon catheters for the treatment.
The major market players operating in the APAC region are Cardinal Health Inc., Biotronik Se & Co. KG, Cook Medical LLC, Medtronic PLC, Boston Scientific Corporation, Microport Scientific Corporation, Spectranetics, B Braun Melsungen AG, Abbott Laboratories, C. R. Bard, Inc., Endocor GmbH, Cordis and Terumo Corporation.